Demonstrates bioassembly of tendon fibroblast spheroids to create tenogenic constructs, suggesting potential for tendon repair applications.
Tissue-engineered tendon constructs that replicate the structural and functional properties of natural tendons are crucial in regenerative medicine to improve treatment outcomes after tendon injury. This study aimed to engineer 3-dimensional biomimetic tendon macro-tissues through bioassembly of cell spheroids. Rat tendon fibroblasts seeded at different cell numbers (1×10⁴, 5×10⁴, 1×10⁵, 2×10⁵, 3×10⁵) were analysed for spheroid formation and development for 28 days. The spheroid diameters decreased over time with a reduction in cell density while synthesising their own collagen fibres. Spheroids were then bioassembled to form fused macro-tissue constructs using pillar array temporary supports. With the presence of ascorbic acid in growth media, the spheroids fused within 6 days after bioassembly, during which the supports were removed, leaving the constructs scaffold-free. The fused spheroids reorganised over time with increased fibrillar collagen content, showing elongated cell morphology in peripheral regions, which were parallelly aligned with collagen fibres resembling natural tendon micro-anatomy. The presence of scleraxis and tenomodulin gene markers also supports the tenogenic nature of tissue constructs. These biomimetic scaffold-free tenogenic macro-tissues have promising applications in tendon repair and regeneration, as in vitro models and tendon graft substitutes.
No takes yet. Share an insight, caveat, or question.
Prabhakaran et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: